07:00 , Jul 23, 2009 |  BC Innovations  |  Distillery Therapeutics

Indication: Cancer

Indication Target/marker/pathway Summary Licensing status Publication and contact information Cancer Brain cancer Polymerase (DNA directed), delta 2, regulatory subunit 50kDa (POLD2); cytochrome c, somatic (CYCS); metallothionein 1A (MT1A; MTC); aldo-keto reductase family 1, member C3...
08:00 , Dec 18, 2008 |  BC Innovations  |  Distillery Therapeutics

This week in therapeutics

The Distillery: Therapeutics Indication Target/marker/pathway Summary Licensing status Publication and contact information Cancer Brain tumors Cytochrome c, somatic (CYCS); X-linked inhibitor of apoptosis (XIAP) Studies in cell culture suggest that increasing levels of oxidized CYCS...
08:00 , Dec 18, 2008 |  BC Innovations  |  Targets & Mechanisms

Cancer's fuel duel

A team of Belgian and U.S. researchers has demonstrated that hypoxic tumor cells can be killed by targeting solute carrier family 16, member 1 (monocarboxylic acid transporter 1), a membrane lactate transporter protein expressed on...
07:00 , Jun 12, 2008 |  BC Innovations  |  Targets & Mechanisms

Eyeing New Uses for Protease Inhibitors

A paper in the...